242 related articles for article (PubMed ID: 16829237)
1. Phase I research and the meaning of direct benefit.
Ross L
J Pediatr; 2006 Jul; 149(1 Suppl):S20-4. PubMed ID: 16829237
[TBL] [Abstract][Full Text] [Related]
2. Pediatric research posing a minor increase over minimal risk and no prospect of direct benefit: challenging 45 CFR 46.406.
Iltis A
Account Res; 2007; 14(1):19-34. PubMed ID: 17847605
[TBL] [Abstract][Full Text] [Related]
3. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.
Fisher CB; Kornetsky SZ; Prentice ED
Am J Bioeth; 2007 Mar; 7(3):5-10. PubMed ID: 17366219
[TBL] [Abstract][Full Text] [Related]
4. How do institutional review boards apply the federal risk and benefit standards for pediatric research?
Shah S; Whittle A; Wilfond B; Gensler G; Wendler D
JAMA; 2004 Jan; 291(4):476-82. PubMed ID: 14747505
[TBL] [Abstract][Full Text] [Related]
5. Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.
Baer GR; Nelson RM;
Clin Ther; 2006 Sep; 28(9):1399-407. PubMed ID: 17062312
[TBL] [Abstract][Full Text] [Related]
6. Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
Anderson BD; Adamson PC; Weiner SL; McCabe MS; Smith MA
J Clin Oncol; 2004 Dec; 22(23):4846-50. PubMed ID: 15570088
[TBL] [Abstract][Full Text] [Related]
7. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.
Wendler D; Belsky L; Thompson KM; Emanuel EJ
JAMA; 2005 Aug; 294(7):826-32. PubMed ID: 16106008
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic misconception in early phase gene transfer trials.
Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
[TBL] [Abstract][Full Text] [Related]
9. Minimal risk in pediatric research as a function of age.
Wendler D
Arch Pediatr Adolesc Med; 2009 Feb; 163(2):115-8. PubMed ID: 19188642
[TBL] [Abstract][Full Text] [Related]
10. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?
Miller FG; Joffe S
Clin Trials; 2008; 5(6):617-23. PubMed ID: 19029210
[TBL] [Abstract][Full Text] [Related]
11. Descriptions of benefits and risks in consent forms for phase 1 oncology trials.
Horng S; Emanuel EJ; Wilfond B; Rackoff J; Martz K; Grady C
N Engl J Med; 2002 Dec; 347(26):2134-40. PubMed ID: 12501226
[TBL] [Abstract][Full Text] [Related]
12. Children are not small adults: documentation of assent for research involving children.
Ungar D; Joffe S; Kodish E
J Pediatr; 2006 Jul; 149(1 Suppl):S31-3. PubMed ID: 16829240
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the level of risk in pediatric research: an ethical examination of the federal regulations.
Dyson M; Parsi K
J Clin Ethics; 2010; 21(3):212-20. PubMed ID: 21089990
[TBL] [Abstract][Full Text] [Related]
14. [Pediatric research is necessary. The children must be guaranteed with a complete protection].
Dahlquist G
Lakartidningen; 2004 Jun; 101(26-27):2238-9. PubMed ID: 15281622
[No Abstract] [Full Text] [Related]
15. Does it matter whether investigators intend to benefit research subjects?
Wendler D; Abdoler E
Kennedy Inst Ethics J; 2010 Dec; 20(4):353-70. PubMed ID: 21338029
[TBL] [Abstract][Full Text] [Related]
16. Acceptable risks and burdens for children in research without direct benefit: a systematic analysis of the decisions made by the Dutch Central Committee.
Westra AE; Sukhai RN; Wit JM; de Beaufort ID; Cohen AF
J Med Ethics; 2010 Jul; 36(7):420-4. PubMed ID: 20605997
[TBL] [Abstract][Full Text] [Related]
17. Conducting ethical research in pediatrics: a brief historical overview and review of pediatric regulations.
Diekema DS
J Pediatr; 2006 Jul; 149(1 Suppl):S3-11. PubMed ID: 16829239
[TBL] [Abstract][Full Text] [Related]
18. The legal ethics of pediatric research.
Coleman DL
Duke Law J; 2007 Dec; 57(3):517-624. PubMed ID: 18354870
[TBL] [Abstract][Full Text] [Related]
19. Children in clinical research: a conflict of moral values.
Sharav VH
Am J Bioeth; 2003; 3(1):W-IF 2. PubMed ID: 14560714
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.
Kimmelman J; Palmour N
J Med Ethics; 2005 Apr; 31(4):209-14. PubMed ID: 15800361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
